Home Newsfeeds B of A Securities Upgrades Radian Group to Buy, Announces $24 Price Target

B of A Securities Upgrades Radian Group to Buy, Announces $24 Price Target

B of A Securities analyst Mihir Bhatia upgrades Radian Group (NYSE:RDN) from Neutral to Buy and announces $24 price target.

byBenzinga Newsdesk

December 15, 2022

1 minute read

B of A Securities analyst Mihir Bhatia upgrades Radian Group (NYSE:RDN) from Neutral to Buy and announces $24 price target.

Akamai Technologies, Array Technologies Music, HNI, PENN Entertainment And Other Big Stocks Moving Higher On Wednesday

By Lisa Levin

August 9, 2:03 PM

U.S. stocks traded lower, with the Nasdaq Composite falling around 100 points on Wednesday. Here are some big stocks recording gains in today’s session.

AKAM

Movers
News

What’s Going On With Rocket Companies Stock After Hot Inflation Data?

By Erica Kollmann

April 10, 12:51 PM

The CPI data came in at 3.5% year-over-year, versus the estimated 3.4% leading many investors to think the Federal Reserve will leave interest rates higher for longer. Investors may be viewing the possibility of fewer rate cuts as negative news for Rocket as a mortgage provider.

RKT

Valaris Misses Q3 Earnings On Weak Floater Revenue Efficiency & Contract Delays

By Lekha Gupta

November 7, 6:44 AM

Valaris Ltd (NYSE: VAL) reported Q3 2023 revenues of $455.1 million, missing the

VAL

News

Cadence Expands Pfizer’s License To Molecular Design Software

By Benzinga Newsdesk

October 25, 10:46 AM

Includes access to computational software designed to help advance innovation in traditional and AI-based drug discoveryCadence Molecular Sciences (OpenEye)—a business unit ofCadence Design Systems

CDNS

B of A Securities Upgrades Radian Group to Buy, Announces $24 Price Target

Related Posts

Akamai Technologies, Array Technologies Music, HNI, PENN Entertainment And Other Big Stocks Moving Higher On Wednesday

What’s Going On With Rocket Companies Stock After Hot Inflation Data?

Valaris Misses Q3 Earnings On Weak Floater Revenue Efficiency & Contract Delays

Cadence Expands Pfizer’s License To Molecular Design Software